|
Volumn 92, Issue 2, 2012, Pages 262-264
|
Raising orphans: How clinical development programs of drugs for rare and common diseases are different
|
Author keywords
[No Author keywords available]
|
Indexed keywords
DRUG;
NONORPHAN DRUG;
ORPHAN DRUG;
UNCLASSIFIED DRUG;
VACCINE;
ARTICLE;
CARDIOLOGY;
CLINICAL TRIAL (TOPIC);
DERMATOLOGY;
ENDOCRINOLOGY;
FOOD AND DRUG ADMINISTRATION;
GASTROINTESTINAL TRACT;
HEMATOLOGY;
HUMAN;
IMMUNOLOGY;
INFECTION;
METHODOLOGY;
NEUROLOGIC DISEASE;
NEUROSCIENCE;
ONCOLOGY;
OPHTHALMOLOGY;
PRIORITY JOURNAL;
PULMONOLOGY;
RANDOMIZATION;
RARE DISEASE;
RESPIRATORY SYSTEM;
UROGENITAL SYSTEM PARAMETERS;
DRUG APPROVAL;
DRUG DISCOVERY;
HUMANS;
ORPHAN DRUG PRODUCTION;
RANDOMIZED CONTROLLED TRIALS AS TOPIC;
RARE DISEASES;
RESEARCH DESIGN;
SAMPLE SIZE;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84864133268
PISSN: 00099236
EISSN: 15326535
Source Type: Journal
DOI: 10.1038/clpt.2012.87 Document Type: Article |
Times cited : (22)
|
References (4)
|